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Identifying people with advanced illnesses whose health is deteriorating, assessing 
their needs and planning care proactively with them are healthcare priorities given 
the demographic trend of ageing populations in the UK and internationally. Over the 
past 10 years (2004-2014), I have led a series of research studies that have made an 
important academic contribution to improving palliative care services for patients 
with heart disease and advanced multimorbidity. 
 
My first paper reported secondary analysis of data generated from a qualitative study 
of the illness and care experiences of patients with advanced heart failure. This work 
used innovative, qualitative research methods to explore and understand patient, 
carer and health professional perspectives over time. My second study then evaluated 
whether health and social care services were configured and delivered in response to 
the needs of people with heart failure and their families. This led me to recommend 
an anticipatory care framework which integrated a palliative care approach with 
other aspects of treatment and care. Around this time, advance care planning 
(planning ahead to facilitate end-of-life care aligned with people’s goals and 
preferences) was being strongly advocated by NHS health policy makers despite 
limited research in the UK. For my third study, I evaluated an evidence-based, 
educational intervention for general practitioners while also exploring barriers and 
facilitators to advance care planning in primary care for patients with cancer or other 
advanced conditions.   
 
It was becoming increasingly clear that failure to identify people with deteriorating 
health and a high risk of dying in a timely way was a major barrier to more effective 
palliative care. The problem was greatest for patients with non-malignant conditions 
whose illness trajectory is much less easy to predict than in cancer populations. I 
therefore started to research and develop a new clinical tool designed to prompt 
early, proactive patient identification in routine clinical practice – the Supportive and 
Palliative Care Indicators Tool (SPICT). My fourth research paper reported an 
evaluation of the SPICT in a mixed-methods study in a large tertiary care hospital. 
The SPICT was then used to identify people with multimorbidity for my fifth study, 
a longitudinal exploration of patient and carer experiences of hospital admission and 
ongoing community care.  
 
In my final paper, I drew on my previous research and combined this with well-
developed approaches to timely identification and effective communication. I 
described the design of a successful pilot randomised trial of future care planning 
with people who had advanced heart disease and their carers.   
 
This thesis presents a critical review of these six research studies setting them in 
context and demonstrating the impact they have had in ensuring that high quality 
research evidence informs current and future developments in palliative care policy 






The number of older people with advanced illnesses in the UK and other countries is 
increasing. It is important to identify these people and find out what help and support 
they need so that we can make sure their treatment and care is as good as it can be 
when their health is deteriorating, and then when they are dying. In these six papers, 
I have described research work that aimed to help improve supportive and palliative 
care for people with advanced heart disease or multiple advanced, progressive 
illnesses. 
 
My first paper described a research study where people with advanced heart failure 
and the family members who cared for them told us about their experiences of living 
with poor health due to heart disease and about how well they thought health and 
social care services responded to their needs. We spoke to them in a series of 
interviews spread out over a year. We also interviewed the professionals nominated 
by the patients as most involved in their care at the same times to gain their views 
and suggestions about improving care. For my second study, we again interviewed 
patients with heart failure, their carers and key professionals up to three times over 
12 months. This study focused more on whether health and social care services were 
organised and provided in ways that help people with advanced heart failure and 
their families the most. Advance care planning (planning ahead with patients and 
their families to try to make sure that when someone is dying treatment and care is 
given which is in line with that person’s goals and preferences) has been 
recommended as part of palliative care developments in the UK. My third paper 
looked at advance care planning being offered by general practitioners to their 
patients with cancer and some other advanced conditions to try and understand more 
about whether it was helpful.  
 
We need to identify people with deteriorating health who are at risk of dying so they 
can receive good palliative care. When people have advanced illnesses these are 
more unpredictable than cancer. I developed a guide called the ‘Supportive and 
Palliative Care Indicators Tool’ (SPICT) to help professionals to identify people with 
unmet needs who could be helped by a palliative care approach. I.  My fourth 
research paper, reported a study testing the SPICT in a large teaching hospital. The 
SPICT was then used to identify people with multiple advanced illnesses for my fifth 
study. People who took part were interviewed to find out about their experiences of 
an emergency hospital admission and their care once they were back at home again. 
In my final paper, I described how we designed a pilot, randomised trial of future 
care planning with patients who had advanced heart disease and their informal carers.  
 
This thesis presents a critical review of these six linked research studies. I have 
explained their background and importance in helping to make sure that research 





For the past 15 years, I have had the great pleasure and privilege of being a member 
of the Primary Palliative Care Research Group at the University of Edinburgh. It is as 
a member of this wonderful team of colleagues that I have gained the best possible 
training in palliative care research as we have worked on these studies and many 
other interesting and valuable projects. By sharing our experiences and learning with 
and from each other, we have achieved far more than would otherwise have been 
possible. 
 
My mentor and friend throughout this time has been Scott Murray who has led our 
group with wisdom, integrity and enthusiasm combined with endless patience and 
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Thank you, Scott. 
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has shown us how to turn a supportive and palliative care intervention into a robust 
clinical trial. Other members of our research group have helped me along the way 
and each of them has made their own unique contribution to our combined efforts. 
Morag Edwards our superb administrator, keeps us all organised and like everyone 
else I could not manage without her. 
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1. Introduction: palliative care for people with any advanced illness  
 
‘Palliative care is an approach that improves the quality of life of patients and 
their families facing the problems associated with life-threatening illness through 
the prevention and relief of suffering by means of early identification, assessment 
and treatment of physical, psychosocial and spiritual problems’  
         WHO 2002 
It is now widely accepted that identifying people with advanced illnesses whose 
health is deteriorating in systematic and timely ways, assessing their unmet needs, 
and planning care with them are priorities given the demographic trend of ageing 
populations in the UK and internationally. This was not the case fifteen years ago 
when I embarked on the research presented in this thesis. Hospice based, specialist 
palliative care services were increasingly available in countries like the UK, USA 
and Canada, but most still focused on caring for people dying of cancer and a small 
number of neurological conditions. Hospice services were predominantly community 
orientated and aimed to support people dying at home or, if that proved to be too 
difficult, in a hospice inpatient unit. (1) The landmark American ‘Study to 
Understand Prognoses and Preferences for Outcomes and Risks of Treatments’ 
(SUPPORT), published in 1995, focused attention on the pressing need to improve 
care of seriously ill people dying with a much wider range of conditions and in acute 
hospitals. (2) The SUPPORT trial failed to show any impact from promoting advance 
directives and eliciting patient preferences on professional decision-making. (3) 
However, wider healthcare policy, research and education were starting to pay 
attention to patient perspectives in shaping and improving services instead of relying 
on proxy information from surveys of bereaved relatives. (4) A programme of 
research involving people living with common, advanced non-malignant conditions 
whose prognosis was just as poor as that of people with many common cancers was 
needed. (5) People with advanced long term conditions such as heart failure or end-
stage chronic obstructive pulmonary disease were rarely in receipt of any form of 
palliative care. (6) Most of them were dying in acute hospitals during an acute 
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exacerbation of their condition despite spending most of the last year of life at home 
being looked after by general practitioners and other community based services. (7) 
 
In 1998, a study of patient, carer and professional perspectives of palliative care for 
people with cancer in Scotland was being mooted by clinical academics, senior 
clinicians and policy makers in NHS Lothian. Inoperable lung cancer was selected as 
it was the commonest and most lethal malignancy in Scotland. Many people with 
lung cancer were diagnosed late and their illness followed the archetypical, rapidly 
declining cancer trajectory. (8) (9) I proposed including a comparison group of 
people with advanced heart failure recruited from the acute hospital where I was 
working as a palliative medicine specialist. Our in-depth study of the experiences of 
people with advanced lung cancer or advanced heart failure used a novel, 
longitudinal, qualitative approach to data generation and analysis. This consisted of 
serial interviews with patients, carers and their nominated key professionals at three 
monthly intervals for up to a year. We later published a description of this 
methodological approach. (10) We also integrated multiple narratives from different 
patient and professional perspectives to gain a broader understanding of people’s 
evolving experiences and concerns over time. (11) A strength of working as a 
research team with complementary professional backgrounds (a primary care 
academic, a palliative medicine specialist, a nurse academic and a social scientist) 
was our ability to bring diverse perspectives to data interpretation and synthesis. (12) 
My clinical work seeing people with many advanced, progressive illnesses including 
heart failure, enabled me to bring valuable insights to the research process as our 
multidisciplinary research team read and re-read the interview transcripts, discussed 
emerging themes and reached consensus about the final data interpretation. This 
iterative process was a key part of the ongoing analysis that accompanied and 
informed data generation throughout the study. We published the findings of this 
study in the British Medical Journal and highlighted the different needs and 
experiences of people with heart failure and the lack of well developed models of 





2. Living and dying with advanced heart failure: experiences of 
patients, families and professionals. (Paper 1) 
 
‘I’m alive but it’s no life...’   
     (Patient with advanced heart failure) 
 
In the late 1990’s, nurse-led interventions to reduce hospitalisation and 
implementation of evidence-based, drug treatments for left ventricular failure 
dominated research efforts into the care of people with advanced heart disease. (14) 
(15) (16) A few smaller qualitative studies had explored people’s information needs, 
their coping strategies and some of the challenges of communication and decision-
making for people living with heart failure but only at single time points in the illness 
trajectory. (17) (18) However, it soon became evident in our comparative study of 
people with lung cancer and people with heart failure that my clinical impression of 
considerable unmet need among people living with advanced heart failure was 
present in our study group. I therefore decided to lead a secondary analysis of the 
data generated from the 20 patients who had heart failure to explore this further. The 
data, including the fully transcribed interviews, had already been entered into the 
qualitative data analysis package, NVivo, so could be accessed for this work. 
Reservations about subsequent analysis of qualitative data often centre on concerns 
that secondary analysts will lack the detailed, contextual knowledge about the 
circumstances of the original data collection held by the primary researcher who 
generated the data. Classically, secondary analysis involves analysis of data 
deposited in a research archive by a different research team. However, it is common 
practice for qualitative as well as quantitative data collected by one member of a 
research team to be analysed subsequently by others who were active participants in 
the research project. (19) An iterative process of data generation, interpretation, 
analysis and further data generation is central to the methodology of an in-depth 
qualitative interview study like this one. When I returned to the data, it was to look in 
more detail at the themes that had already emerged and to describe those themes 
relating to the experiences of people with heart failure in more depth. Being fully 
involved in the study from the beginning meant that I had already been contributing 




Patients and carers often recount their experiences in narrative form. Illness stories, 
such as those we heard, tend to have a beginning, middle and end with various 
specific events forming the plots and subplots in a temporal, causal sequence. 
Professionals are expected to describe patients they have cared for in terms of 
histories and formal case reports, but they also make frequent use of anecdotes and 
personal stories. (20) Use of a narrative analysis framework with our data was 
helpful in retaining the cohesion of individual stories about people’s experiences 
while also looking for common and contrasting themes across the evolving accounts 
of patients, carers and professionals. In addition, the analysis of narratives provided a 
critical way of examining not just the accounts of individuals or groups (patients, 
carers, or professionals), but also norms and conventions such as concerns about 
openly discussing death and dying or the meanings attached to ‘palliative care’. (21) 
(22) 
 
A total of 112 interviews were available and comprised; patients (50), informal 
carers (27), professionals (30), bereavement interviews (5). A diverse group of 16 
key professionals had discussed the interview findings as part of the original study 
and that transcript was also reviewed for data about care of people with heart failure. 
Many of the people that we interviewed were elderly, with multiple co-morbidities in 
addition to heart failure so they had much in common with the participants in my 
later studies (Papers 2, 4 and 5). (23) People often struggled with many dimensions 
of poor physical and psychosocial health, and they lacked information or any 
meaningful opportunities for care planning.  
‘I slipped down the bed and I could not get my breath. I felt, oh I cannot really, you 
cannot tell people what it’s like.’ (Patient 1) 
‘The sickness makes me feel lousy. I am taking that many tablets now, you sort one 
thing out and it starts another.’ (Patient 3) 
‘He is fading away before my eyes but it could be another year or two or it could be 
another week or two, or it could be tomorrow. I don’t know.’ (Carer 6) 
 
The care provided was often poorly coordinated and unresponsive to their needs with 




‘I suppose I am expecting it to be something catastrophic, so planning and 
discussing it is not really an issue.’ (General practitioner 14) 
‘They told us they had a plan. They said, we have a plan that if she arrests we will 
not be resuscitating her. Just as if it was nothing. It was terrible.’ (Daughter of 
patient 7) 
 
The focus group participants agreed that much needed to be done to improve care for 
people with advanced heart failure and highlighted several key factors to be 
addressed. Better information and a shared language for discussing the condition of 
heart failure would provide a good foundation for talking about the illness, its 
treatment and what might happen. Flexible models of holistic care that can adapt to 
different personal, family and illness circumstances were also deemed important as 
well as collaborative working between hospital specialists, primary care teams and 
specialist palliative care services. I concluded the discussion in my paper by 
proposing a holistic approach to patient and family care, integrated across primary 
and secondary care and delivered in parallel with active treatment of reversible 
underlying conditions. These recommendations have remained unchanged in the 
intervening ten years, albeit underpinned by a much larger evidence base to which 
my research has contributed. (24)    
 
The accompanying editorial in the European Journal of Heart Failure highlighted the 
importance of recognising that conventional treatment does not prevent people with 
heart failure from having intrusive symptoms and a poor quality of life as they live 
with what is ultimately a progressive, terminal illness. Ward, a cardiologist himself, 
acknowledged that many heart specialists were treating patients in order to relieve 
symptoms or to prolong life and they assumed that this would improve its quality. 
The absence of a holistic view of patient and family concerns and experiences 
exacerbated this problem. While commending our research, he called for action to 
move forward from a better understanding of the problems and challenges needing to 
be addressed, into making concrete proposals for changing treatment and care. (25) I 




3. Developing services for people with heart failure and their families: a 
new framework. (Paper 2) 
     
    ‘I’m not frightened of dying, but I want to live…’   
(Patient with advanced heart failure) 
 
In the first few years of the new millennium, advanced heart disease was more 
clearly identified as a major public health problem. (26) Substantial numbers of 
mainly older people were now living in the community with advanced heart failure 
and the additional burden of multiple co-morbidities. (27) Repeated hospitalisations 
and hospital deaths were common, and care was expensive but poorly coordinated. 
(28) At the same time, new policy documents and guidance were being developed to 
address the unmet needs of this patient group. Initially, these targeted delivery of 
evidence-based approaches to the medical management of people with left 
ventricular failure in an attempt to reduce morbidity and hospital admissions. 
However, acceptance that heart failure is a life-limiting condition with a poorer 
outcome than many cancers meant attention was finally directed towards supportive 
and palliative care. (29) (30) 
 
It was therefore timely to extend the scope of our earlier work, take account of the 
new policy recommendations and explore the potential challenges of applying them 
in clinical practice. I led a grant application by our research group to the British 
Heart Foundation/ Department of Health programme and we started a two year study 
in 2002. Our goal was to integrate and explore the perspectives of a diverse sample 
of patients recruited in primary care and secondary care (cardiology and medicine of 
the elderly services), their informal carers, and the professionals caring for them. In 
addition, we sought to move from understanding people’s experiences of health and 
social care service delivery to making concrete and practical recommendations that 
would inform future service developments. A combination of approaches to data 
generation and analysis best suited this aim. We again used a longitudinal, narrative 
analysis of case-linked interview triads and two qualitative researchers conducted 
162 multi-perspective interviews with 30 patients, 21 family carers and 41 key 
professionals. (11) In addition, we convened three multi-professional focus groups to 
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gain a broad perspective of clinical and service management perspectives. A group of 
patients and carers from our local heart failure service users’ forum also met to 
discuss the findings of the study and contributed to the final report. An experienced 
facilitator moderated the discussions and encouraged group interaction and problem 
solving. The interviews and focus group discussions were digitally recorded and 
transcribed for analysis with the aid of the computer package NVivo. Some focus 
group participants did provide further narratives that complemented those we had 
already generated from the interviews. However, we were particularly interested in 
hearing about suggest approaches to service redesign and improvement so we 
adopted a more ethnographic approach to analysis of the focus group data. This made 
it possible to retain a sense of the group discussion as a whole and the health and 
social care context within which the participants worked or lived. (31) 
 
As in my earlier study, difficulty accepting the inherent uncertainties found in the 
illness trajectory of advance heart failure was widespread among patients, carers and 
professionals. (9) (32) (33) This delayed the identification of patients and hindered 
more open discussions about what might happen as their health deteriorated and how 
care could be planned and coordinated: 
‘I think it takes a while for that penny to drop. We don’t switch very well into 
palliative mode. We like to make them feel better.’ (Cardiologist 1) 
 
‘If you’d asked me two and a half years ago if I thought she was going to be here this 
summer, I’d have said no. That’s why I’d be more reticent about talking about dying 
with somebody with heart failure than somebody with cancer.’ (General practitioner, 
Patient 25) 
 
As I will show later in this review, the problems associated with ‘prognostic 
paralysis’ remain one of the greatest barriers to integrated, early palliative care. 
Inequalities between people with left ventricular failure who received structured 
support from a key professional (usually a heart failure nurse specialist) and those 
who had other forms of heart disease or complex multi-morbidity were evident, as 
were the challenges of delivering effective shared care for people in the community. 
I will discuss participatory research and education in the next section, but this study 
was also based on an explicit commitment to engaging with our participants in ways 
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that would enable us all to work together to generate realistic solutions that might 
have a positive impact on the way care could be delivered and accessed in the future. 
Patients and carers we interviewed were sent a lay summary of the key findings with 
an invitation to add their thoughts and comments. The focus group participants were 
asked specifically to help me to develop and refine ‘A service framework for 
coordinated care of people with heart failure’ and it was published as an Appendix to 
the paper. (34) The Appendix was subsequently reproduced with permission in a 
position statement published after the 2009 palliative care workshop of the Heart 




4. Advance care planning in primary care is ‘easier said than done’. 
(Paper 3) 
‘You can lead a horse to water, but you cannot make it drink.’ 
         English Proverb 
By 2008, when I conducted my next study, advance care planning was being strongly 
advocated by NHS health policy makers despite limited research in the UK. The rise 
to prominence of advance care planning in end of life care can be traced back to the 
SUPPORT study I mentioned previously. This landmark study in American hospitals 
suggested that specialists and teams were not taking account of previously expressed 
wishes and preferences about treatment limitations when caring for people who were 
dying. (3) Advance care planning was seen as a structured process enabling people to 
make and document an advance refusal of life-prolonging interventions well ahead of 
the actual situation where those decisions would apply. This type of advance care 
planning gained support because it resonated with societal and cultural values of 
personal autonomy (enshrined in Patient Self-Determination Act of 1990). There was 
a consensus that people should have greater choice and control over their care at the 
end of life. In addition, patients, families, health professionals and policy makers 
were becoming increasingly concerned about the burdens and escalating costs of 
intensive hospital treatments in the last weeks of life and the  ‘medicalisation’ of 
death and dying. Fried has traced the historical evolution of advance care planning in 
the USA. She highlighted the tensions between the two major factors underlying its 
endorsement as a key health policy. On the one hand, the drive to reduce the 
spiralling costs of care in the last months of life could mean that too much attention 
was being paid to deciding what treatments people would not get at the end of life. 
On the other, encouraging open dialogue about decision-making when people are 
deteriorating and dying has many benefits. (36)  
 
Advance care planning internationally did evolve into a broader process of 
discussing and recording a person’s preferences concerning goals of care and it was 
widely promoted for people who may lose capacity or communication ability in the 
future. (37) In the USA, Australia and parts of the UK, advance care planning came 
to be seen as a central element of good palliative and end-of-life care. (38) (39) (40) 
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In an American multi-centre, cohort study of people with cancer and their carers, 
37% reported having end-of-life discussions and this was associated with a lower 
rate of medical interventions and earlier hospice referral. (41)  A small, randomised 
trial with elderly people in Australia showed an increase in patient’s wishes being 
known and followed if they were admitted to hospital. (42) In the UK, the view that 
dying at home was the best and preferred option for many more people, led to place 
of care and place of death becoming the ‘choice’ most often discussed and 
documented as part of advance care planning. The intended outcomes were avoiding 
unplanned hospital admissions, reducing hospital deaths and facilitating a timely 
transition to holistic palliative care focused on quality of life. (43) People spend 90% 
of their last year of life living in the community and advance care planning 
discussions should ideally be offered when people are more stable and at home. 
Consequently, in 2009, UK national policy makers and the Royal College of General 
Practitioners proposed that all general practitioners should be required to identify the 
patients they considered likely to die in the next 12 months using the Gold Standards 
Framework and offer to discuss end-of-life care and advance care planning with 
those patients and their families. (44) 
 
For my third study, we obtained a grant from Cancer Research UK to pilot a mixed-
methods educational intervention on advance care planning for general practitioners. 
Mixed-methods approaches in palliative care research offer a valuable way to 
generate data from different and complementary sources that can be synthesised to 
build a better understanding of the complex and multifaceted experiences and 
situations found in real life clinical settings and are recommended in the initial 
phases of trial design. (45) The study focused on patients with cancer as they are 
more likely to be identified for palliative care than people with other advanced, 
progressive conditions and we recruited a diverse sample of practices. We appointed 
an experienced, social science researcher who was independent of the intervention to 
conduct the evaluation and attend the workshops as an observer to record field notes. 
I worked closely with the researcher throughout the study sharing the data analysis 
and interpretation with him. The researcher visited each practice before and three 
months after the intervention to explore barriers and facilitators to advance care 
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planning in primary care and elicit perceptions about the impact and effectiveness of 
the educational intervention. He asked the practice staff how they thought advance 
care planning could be integrated into their working practices and conducted semi-
structured interviews with 20 general practitioners and eight community nurses. I 
have extensive experience of facilitating clinical communication educational sessions 
for health professionals so I led the workshop at each of the practices. We used a 
well established, evidence-based interactive communication teaching method in 
which participants generate scenarios from their own clinical practice and these form 
the basis of the simulated patient interviews used in the workshop. (46) (47) Each 
practice also received a resource pack consisting of consensus-based guidance on 
how to approach conversations about deteriorating health and planning for end-of-
life care, information about advance care planning, copies of local palliative care 
guidelines, and a draft future care plan for use with patients and families identified 
by their general practitioners during the study. (48)  One of the most striking features 
of the scenarios brought to the workshops was that the patients being identified by 
the participating clinicians for advance care planning seemed to be unaware of how 
ill they were. This left the primary care professionals facing the difficult initial task 
of breaking bad news about a poor prognosis before being able to move on to talking 
about end-of-life care planning. With a small study of this kind, it is important to 
look for generalisability beyond the study setting so the researcher discussed the 
study findings and personal experiences of advance care planning with a purposive 
sample of UK general practitioners with a special interest in palliative care 
(Macmillan GP facilitators). (49)  
 
Our study participants supported many of the core principles underpinning the 
concept of advance care planning, namely respect for autonomy, provision of 
individualised information about prognosis, being able to offer people opportunities 
to talk about future care, and the value of using appropriate planning processes to 
avoid crises when patients are dying. They were very concerned about balancing 
their responsibility to share information about deteriorating health with allowing 
people to maintain positive coping strategies centred on living well in the present. 
Being expected to discuss a preferred place of care at the end of life was particularly 
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problematic for these primary care clinicians and seemed to them to disregard the 
reality of limited care options and the changing circumstances and preferences of 
patients and families. In common with other studies of advance care planning with 
primary care teams, their accounts of attempting these conversations were dominated 
by concern that discussing place of death before the illness was very advanced 
conflicted directly with promoting hope, maintaining normality and letting people 
enjoy as much of their remaining lives as possible. (50) (51) Similarly, our 
participants valued clear and consistent prognostic information from hospital 
specialists, used clinical judgement based on observable signs of deteriorating health 
to prompt a care review and planning discussion and were more likely to identify 
people with advanced cancer. (52) (53) A national survey of physicians caring for 
cancer patients also found that most preferred not to discuss end-of-life options with 
terminally-ill patients who were feeling well but would wait for symptoms to appear 
or until there were no more treatments to offer. (54) The future care planning 
document I developed for the study was modified in response to feedback from our 
participants and published as an appendix to my paper.  Four general practitioners 
used the plan as an aide memoire and a fifth found it to be a helpful tool to support 
conversations with four of her patients. (49) 
 
A recent systematic review from the Netherlands of the effects of advance care 
planning interventions on end-of-life care mainly identified studies that came from 
the USA and from institutional settings. The authors noted that many of the studies 
evaluated advance directives which were used less frequently in the UK and Europe. 
In the American healthcare context where the costs and burdens of ‘medicalisation of 
care’ at the end of life are a major factor for patients and families as well as service 
providers, having an advance directive did have a positive impact on the intended 
outcomes of reducing cardiopulmonary resuscitation, hospitalisation and intensive 
interventions. However, the evidence base for advance care planning per se remained 
poor. (55) Others have argued for a broader view that encompasses not just 
documentation of people’s anticipated wishes but a care planning process that shifts 
the focus from expecting people make premature decisions based on incomplete 
information to preparing patients and their surrogates for the types of decisions and 
conflicts they may encounter when they do have to engage the realities of end-of-life 
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decision-making. (56) (57) (58) It is interesting to see that our findings from six 
years ago resonated with the conclusions of another systematic review from Australia 
published in 2014. This review concluded that factors influencing the uptake of 
advance care planning in palliative care remain complex and multifaceted, with 
facilitators and barriers spanning the social and cultural beliefs of patients, families 
and health professionals, as well as the structural constraints of health and legal 
systems. (59) Patients and their families generally saw advance care planning 
differently from professionals and policy makers. For many people, advance care 
planning meant not only preparing for incapacity, but also preparing for death. 
Engagement with planning was not based solely on a desire for autonomy and the 
exercise of control. People were also concerned with relieving burdens that could be 
placed on others and planning ahead was seen as a social process that occurred 
within relationships with close loved ones. (60) To improve end-of-life care for an 
increasingly multicultural and aging population, we need to increase the flexibility of 
advance care planning and shared decision-making to encompass diverse perceptions 
of autonomy and improve communication and address emotional burdens for 
families when patients lack decision-making capacity. (61) Health professionals are 
called upon to find courage and competence in discussing, delivering and evaluating 
accessible and flexible systems of care that support what matters most to individuals 
rather than fitting people into reductionist, pre-conceived notions about what 
constitutes a ‘good death’. (62) Pollock too has argued cogently that we need to 
move away from the widely promoted view that advance care planning should give 
priority to well-planned dying at home and replace this with anticipatory care 
planning that aims to enhance the quality of care offered to people who die in any 
care setting. (63) 
 
Difficulty in identifying people whose health is deteriorating has remained one of the 
greatest problems restricting access to a palliative care approach and effective care 
planning for people with advanced conditions. This was the subject of the main study 
presented in this critical review and is discussed in the next section. In my final two 
papers, I will return to the subject of future care planning and differentiate between 




5. Identifying people with deteriorating health for supportive and 
palliative care assessment: development and evaluation of the 
Supportive and Palliative Care Indicators Tool (SPICT). 
(Paper 4) 
‘Medicine is a science of uncertainty and an art of probability.’ 
        Sir William Osler 
“Prediction is very difficult, especially about the future” 
Niels Bohr, Physicist 
Timely identification of people who are deteriorating and may die in the foreseeable 
future, assessment of any supportive and palliative care needs, and well-coordinated, 
future care planning in line with their goals and preferences are regarded widely as 
prerequisites for effective care and are key elements of health care policies in the UK 
and internationally. (64) (65) (66) (67) This is all the more pressing given the 
numbers of people dying each year who could potentially benefit from some form of 
palliative care. A population study estimating palliative care needs in England used 
linked mortality and hospital episode data to show that in high-income countries like 
the UK, 69%–82% of those who die could benefit from palliative care. Murtagh, 
Bausewein (68) Clark et al. conducted a detailed prevalent cohort study of just over 
10,000 Scottish, acute hospital inpatients on a single day in 2010. (69) After 12 
months, 28.8% of the patients had died: 3% by 7 days, 9% by 30 days, 21% by 6 
months, and 26% by 9 months. The timing of those deaths followed a non-linear 
trajectory with 32% of all the deaths occurring during the index hospital admission 
and two-thirds happening within the initial 6 month period. Mortality rose steeply 
with age and was associated with social deprivation and multimorbidity. In frail older 
people, the risk of dying remained elevated during the 30 days after discharge from 
an unplanned hospital admission before returning to the population norm. (70)  (71) 
Unplanned hospital admissions are an important indicator of deteriorating health, 
with a marked rise in admissions occurring in the final months of life. (72) It is 
equally important to offer better future care planning to people at risk of loss of 
capacity due to progressive illness. We also need to plan ahead with people who are 
very frail but apparently more stable, such as care home residents, because their final 
deterioration may be relatively sudden and “unexpected”. (73) 
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It is clear that uncertainty about the timing and outcome of acute episodes of 
deteriorating health in the final years and months of life characterises many illness 
trajectories including organ failure, frailty and multimorbidity. This unpredictable 
risk of dying commonly leads to delays in patient identification. (74) (75) (76) (77) 
(78) General practitioners and hospital doctors have reported difficulties in deciding 
when to introduce supportive and palliative care, particularly in patients with non-
cancer illnesses. (52) (79) (80) In acute hospitals, frail older people were identified as 
likely to die within a year but this did not trigger the introduction of a palliative care 
approach to their care. (81) As I discussed in the previous section, advance care 
planning is seen as a key policy initiative in many countries and gives added impetus 
to the need for earlier identification. (59) Despite this, robust tools and triggers for 
patient identification are under-developed in contrast with other more established 
guidelines, processes of assessment and care management systems to support better 
palliative and end-of-life care in the UK and internationally. Failure of identification 
limits access to effective and appropriate holistic care for patients with unmet needs 
and hinders effective service improvements.  
In 2010, I was invited to submit an article on recognising key transitions to palliative 
care for a peer reviewed supplement in the British Medical Journal. (82). The article 
included the first version of the Supportive and Palliative Care Indicators Tool 
(SPICT). (83) Working on this article started what to become a continuing interest in 
developing better approaches to patient identification. My fourth paper described the 
further development and evaluation of the SPICT. (84) To set this work in context, I 
will begin by discussing the evidence base for the five main approaches currently 
used to identify patients for palliative care and their underlying premises before 
going on to explain my rationale for developing a new tool (SPICT). This extends the 
literature review that I started for the 2010 paper and have continued as part of the 
wider SPICT programme. Systematic literature reviews of tools for patient 
identification are challenging because neither ‘identify’ nor ‘identification’ are 
MESH terms. (85) I used a combination of pragmatic, ‘snowballing’ approaches as I 
was primarily interested in tools for patient identification that were recommended for 
use in clinical practice. I sought expert opinion from UK hospital specialists and 
from palliative care specialists in the UK, Europe, Australia and North America 
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about the most commonly used tools in their field through personal contacts and 
professional networks. I also reviewed UK government policies and national 
guidelines including those from the National Institute for Clinical Excellence, the 
Scottish Intercollegiate Guidelines Network, the NHS Education Scotland 
Knowledge Network, and the Royal Colleges of Physicians, along with resources 
from the major UK palliative care organisations such as the Scottish Partnership for 
Partnership for Palliative Care and The National Council for Palliative Care along 
with the European Association for Palliative care. Additional papers were identified 
through citation searching. Many tools and approaches were developed with the aim 
of improving prognostication based solely on clinician judgement which is known to 
have a relatively low correlation with actual patient outcomes. Some tools are also 
used to help plan or manage access to treatment and care. (86) (87) (88) Two 
systematic reviews on tools for patient identification for palliative care in primary 
care have been published, but none on tools for use in secondary care. (85) (89) 
The five major approaches to prognostication and identification of patients for 
palliative care tend to be used in combination, and may be classified as follows:  
1. Clinician judgements 
2. Performance status based scores 
3. Palliative care needs assessment tools 
4. Disease specific mortality risk scores 
5. Clinical indicators of advanced conditions 
Most tools rely on application and interpretation by clinicians and some are used in 
combination. I will show how I drew on all five methods of identification in 
developing the SPICT. I also took account of the changing demography towards 
ageing populations with multimorbidity and tried to address the greatest barrier to 
patient identification of all, namely ‘prognostic paralysis’. This is the situation where 
clinicians delay identifying patients for palliative care assessment and care until 
death is seems inevitable and there are no further treatments or interventions 
available to alter this. (54) (75) (90) (91) Finally, I will review the wider SPICT 




Before discussing the five approaches to prognostication and patient identification, I 
would like to refer to Glare’s helpful definition. Glare rightly sets prognostication in 
a broad clinical context and draws on both the art and science of medicine. (87) 
 ‘The physician’s goal is to formulate an individualised prognosis for  the 
patient starting with a generalised prognosis and modifying it using clinical 
observations, performance status, symptoms, co-morbidities, will-to-live and 
knowledge of illness trajectories.’ 
1. Clinician judgements 
Clinician predictors of survival are inevitably subject to a degree of cognitive bias 
but remain a pragmatic and flexible approach to patient identification that is 
anchored in the realities of clinical practice. It is important to note that probabilistic 
predictions are less inaccurate than temporal ones. Clinical experience improves the 
accuracy of these judgements although a long period of involvement in the care of a 
patient can be a confounding factor. (92) In my own study of advance care planning 
in primary care (Paper 3) and in another study from the Netherlands, general 
practitioners used their experience to help them judge when it was time to introduce 
‘palliative care’ but also relied on communication from hospital specialists about 
prognosis and treatment plans. (49) (53)  
 
A tool that has been used widely in the UK and internationally for over 15 years 
when making clinical judgements about prognosis is the ‘Surprise Question’ (SQ). 
This was originally described by an American geriatrician, Joanne Lynn, as a way to 
identify people needing palliative care regardless of their illness trajectory. 
Interestingly, the early iterations of the SQ fully acknowledged the uncertainty of 
prognostication, particularly in relation to duration of survival. Lynn says:  
‘Instead of asking whether the person has a prognosis of some short limit 
(such as having a prognosis of six months, which Medicare regulations in the 
USA require if a patient is to qualify for reimbursement of hospice benefits), 
the clinical team asks, “Is this person sick enough that it would be no surprise 
for the person to die within the next six months, or a year?” Whether one 
looks a few months ahead or a year turns out not to matter much; at stake is 
whether the person is in a fragile enough condition that relatively minor 
23 
 
worsening or intercurrent illnesses could spell the end of life. Some of the 
patients identified by the “Surprise Question” will end up living for years in a 
fragile state, and some will die soon.’ (8)  
The SQ has been used in many countries in primary and secondary care. Including 
the SQ as one of the core elements of the UK Gold Standards Framework (GSF) has 
contributed to its dissemination. (93) The wording of the SQ has been changed in the 
GSF to: ‘Would you be surprised if the patient were to die in the next months, weeks 
or days?’  The focus is therefore more on temporal prediction which, as Glare 
observed, is more inaccurate than probabilistic judgements. This has meant that the 
SQ is often interpreted as referring to a prognosis of less than a year. In their 2010 
definition, the General Medical Council also directs clinicians to consider which 
patients might die within a specific time frame: ‘People are ‘approaching the end-of-
life’ when they are likely to die within the next 12 months. This includes people 
whose death is imminent (expected within a few hours or days).’ (94) By making this 
shift in emphasis, these influential organisations have aligned the current SQ with 
other tools that focus on survival time. The original SQ concept of looking for people 
with a high ‘risk’ of deteriorating and dying has been lost. As a result, binary 
judgements tend to be made about whether a person should, or should not, be 
identified as requiring palliative care. Professionals and services may well be making 
decisions on the basis of prognostic judgements that turn out to be inaccurate and 
unhelpful.  
 
Use of the SQ in patients with cancer and other advanced conditions in hospital and 
primary care settings has been evaluated in a number of countries but there is no 
published systematic review. In a 2010, outpatient clinic study, oncologists 
documented their response to the SQ in nearly 900 consecutive patients. At one year, 
41% of the ‘No surprise’ group had died. The sensitivity of the SQ ‘no’ response was 
75%, and its specificity was 90%. The positive predictive value (PPV) was 41% and 
negative predictive value (NPV) 97%. (95) In a similar study of community patients 
receiving peritoneal dialysis, 25% of identified patients died within a year; the PPV 
of the Surprise Question was 24.8% and its NPV was 93.4%. (96) In an Italian study, 
general practitioners used the SQ to screen their patients with advanced cancer and 
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reported one year survival. The study enrolled around 230 patients and the sensitivity 
of the SQ with sicker cancer patients was 69.3% with a specificity of 83.6%. Around 
31% of SQ ‘No surprise’ patients survived beyond a year. (97) A recently published 
study from Japan screened over 2000 patients receiving palliative care in the 
community and hospitals for short term survival (7 or 30 days) using the SQ. They 
found that screening could identify many of the people who died within 7 or 30 days 
(around 90% sensitivity) but a high false positive rate meant that the SQ could not 
provide a definitive prognosis. (98) 
 
One research group has raised concerns that the SQ may be particularly unsuitable as 
a tool to help general practitioners identify patients with COPD or heart failure for 
palliative care assessment and referral because of the uncertain nature of those illness 
trajectories and the difficulties primary care clinicians had in answering the question. 
They also commented that relying on temporal prognostication risks fostering a 
narrow view of palliative care as only being applicable at the very end of life. (99) In 
another qualitative study with general practitioners, participants were asked to 
identify two of their patients aged over 80 whom the GP thought were likely to die 
within a year for discussion. The GPs had difficulty making prognostic judgements 
unless the patient had a typical, rapidly declining cancer trajectory which was less 
common in their elderly patients. Most of them expressed concern that the Surprise 
Question was too subjective to be the basis for decisions about a poor prognosis.  
Pressure to use the SQ, meant that the general practitioners identified patients ‘too 
soon’ and before the time where they felt comfortable with considering advance care 
planning and terminal care. (100) The SQ may provide a means of articulating 
clinician judgements but its limitations in identifying people for a palliative care 
approach are evident. 
2. Performance status based tools 
Performance status or functional ability is long established in cancer care as a 
measure of disease status, a guide to treatment planning, and the most significant 
single factor in estimating survival time. (101) Combining a performance status score 
with the clinical features of a terminal cancer syndrome (anorexia, weight loss, 
dysphagia and cognitive failure) may improve the accuracy of prognostication, 
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particularly in the final couple of months of life. This is consistent with the 
archetypical cancer trajectory of rapid functional decline before death.(9) (102) 
Building on this, several statistical tools consisting of a Karnofsky performance 
status score combined with clinical and biochemical markers such as serum albumin 
and C-reactive protein have been developed and evaluated, largely in patients with 
cancer. (92) One of the most widely used tools of this type is the Palliative 
Performance Scale (PPS), developed by a Canadian hospice service in 1996 as a 
measure of changing functional status for use in palliative care services. (103) In a 
large, retrospective, cohort study of over 6000 patients referred to this specialist 
palliative care service, reasonable prognostic estimates could be generated for the 
majority of the patients via a nomogram that combined an admission PPS score with 
age, diagnosis, gender and place of care. However, the authors also acknowledged 
the limitations of a single measure of functional status in the context of evolving 
illness trajectories punctuated by ‘sentinel’ acute episodes of deterioration and noted 
that significant numbers of patients had a much shorter or longer than predicted 
survival times. (104)  
More recently, a prospective, multi-centre study in 18 UK specialist services tried to 
develop and validate a new prognostic tool to improve or even replace clinician 
estimates of survival for patients receiving palliative care: the Prognosis in Palliative 
Care Study (PiPS). (105) Eleven core variables including performance status, clinical 
signs and blood tests predicted survival in terms of ‘days’, ‘weeks’ or ‘months’ in 
patients with advanced cancer more accurately than estimates by individual 
clinicians. However, the tool was not significantly more accurate than an assessment 
by the multi-disciplinary team. An expert consensus workshop concluded that a wide 
range of questions remain unanswered about the validity and clinical value of such 
prognostication tools. Stevinson, Preston (88) A recently published study has 
compared the Eastern Cooperative Oncology Group (ECOG) performance status 
scale with the Karnofsky performance scale, and the Palliative Performance Scale in 
a mixed primary cancer, outpatient cohort of people with advanced cancer and an 
estimated prognosis of under a year. All three measures of performance status 
predicted mortality risk effectively. Survival was approximately halved for each 
reduction in ECOG performance level. A simple performance status assessment is 
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practical in routine care and seemed to be as good as more complex measures 
requiring blood tests and calculations. (106) 
3. Palliative care needs assessment tools 
Holistic, needs-based methods of patient identification target people with poorly 
controlled, distressing symptoms despite maximal tolerated therapy and a range of 
other patient and family needs. The field of palliative care needs assessment has been 
dominated in recent years by the Palliative Care Outcome Score (POS). Like the 
shorter hospital Support Team Assessment Score (STAS), the POS was originally 
designed as a brief, practical tool to measure the outcomes of palliative care 
interventions from patient, family carer and professional perspectives. (107) The 
STAS measures symptom control, changes in the insight of patients and families and 
achievement of place of care preferences. The POS was developed from the STAS in 
1999 and has been validated for measuring outcomes with patients who have a wide 
range of advanced illnesses and in many countries. POS can be used as a screening 
tool for unmet supportive and palliative care needs in patients already identified as 
having advanced illnesses and potentially needing palliative care or to complement 
other methods of data collection in studies of patient experiences of care. The 
assessment consists of 10 physical, psychological, information and care domains 
which are scored from 0 (best) to 4 (worst) for a recent period of time, the past 3 
days. There is the option to add a patient’s perceptions of what constitutes their main 
problems or needs. However, some patients, such as those with advanced COPD, 
tended to adapt to a high burden of symptoms and may not benefit fully from 
interventions utilising case finding based on a ‘needs assessment’. (108) A group of 
patients attending a conservative renal management clinic reported a high burden of 
symptoms using the renal version of POS, but there was no relationship between the 
level of renal impairment and symptom prevalence, severity or quality of life. (109)  
In Australia, needs-based assessment has been developed with the aims of promoting 
earlier identification of patients for specialist assessment and ensuring there is a 
robust approach equitable decision-making about ongoing access to specialist 
palliative care services. (110) Like the POS, the Australian NAT-PC tool assesses 
unmet needs across a range of physical, psychological, family/social and existential 
domains but does not attempt to identify those at risk of deteriorating and dying. 
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Needs assessment tools can be helpful in assessing the holistic care needs of 
individual patients as part of managing their care and in evaluating care or services. 
Theoretically, they should enable scarce specialist resources to be targeted towards 
those with severe and complex needs. At present, there is no standardised systematic, 
evidence-based and holistic approach to screening patients for supportive and 
palliative care needs. (111) Such tools are of less value in identifying people whose 
health is deteriorating generally or for prompting conversations about future care 
planning based on a change in the person’s health or circumstances.  
1. Disease specific mortality risk scores 
Disease mortality risk scores are used extensively by hospital-based specialists in 
their clinical practice and in health services research. These tools are often seen as 
the ‘gold standard’ for judging prognosis in patients dying with organ failure. Large 
population studies and refinement of the component measures have aimed to improve 
their predictive value but these tools vary in accuracy and perform less well at the 
individual patient level, particularly now that multimorbidity is an increasingly 
common confounding factor. In ischaemic heart disease, the most widely used 
scoring system is the Global Registry of Acute Coronary Events (GRACE) score 
which estimates risk of death or further myocardial infarction within six months of 
an admission with acute coronary syndrome based on age, blood pressure, heart rate, 
renal function, the severity of any concomitant heart failure and the incident cardiac 
event. (112) In a recent cohort study from New Zealand, the GRACE admission-to-
6-month total mortality and mortality/myocardial infarction scores both 
overestimated event rates by approximately twofold. (113) For populations with 
predominantly left ventricular heart failure, the Seattle heart failure model gives an 
estimate of one-year survival using clinical characteristics (age, gender, systolic 
blood pressure, weight, ejection fraction and heart failure class) laboratory tests (such 
as haemoglobin and sodium) and medications, particularly diuretic dose. It does not 
apply in the growing population of people with right-sided or global heart failure but 
does now incorporate medications and implantable devices that may affect outcomes. 
(114) Another tool from the Canadian Enhanced Feedback for Effective Cardiac 
Treatment (EFFECT) study can be used to predict 30-day and 12-month mortality in 
patients hospitalised with heart failure of any type. Multivariate predictors of 
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mortality at both time points included older age, lower systolic blood pressure, 
higher respiratory rate, raised urea and low serum sodium. Other co-morbid 
conditions associated with increased mortality included cerebrovascular disease, 
chronic obstructive pulmonary disease, hepatic cirrhosis, dementia and cancer. (115) 
All these mortality risk tools are available in the form of online calculators making 
them easier to use. 
The Global Initiative for Obstructive Lung Disease (GOLD) is one of the most 
widely used international systems to guide diagnosis, classification of disease 
severity and treatment in people with advanced chronic obstructive pulmonary 
disease (COPD). It uses post-bronchodilator airflow measurement (FEV1) and 
clinical factors, particularly exacerbations. A recent large study concluded that 
although the GOLD classification may be useful in targeting treatments, it does not 
predict mortality with sufficient accuracy to be useful in clinical practice or research. 
(116) An alternative prognostic tool used to predict mortality risk in patients with 
COPD is the Body mass, airflow Obstruction, Dyspnoea and Exercise (BODE) 
index. The BODE index uses the same measure of airflow obstruction as GOLD 
(FEV1), breathlessness is assessed using the modified Medical Research Council 
dyspnoea scale, and exercise capacity is measured using a 6-minute walk test. It 
predicts mortality and hospitalisation with exacerbations more accurately than 
respiratory function alone. However, formal spirometry is difficult for frail people to 
manage as are structured walking tests, and neither test is readily available in all care 
settings. (117) (118)  
The Model for End-stage Liver Disease (MELD) score combines renal function with 
two markers of poor hepatic synthetic function, bilirubin and the prothrombin time 
international ratio. MELD is widely used to assess mortality risk in end-stage 
cirrhosis and to guide the selection of patients for transplantation. It is simple to 
calculate but fails to predict survival accurately in about 25-30% of patients. (119) 
The United Kingdom End-stage Liver Disease (UKELD) score includes serum 
sodium in addition to the MELD criteria and is the main tool used by UK transplant 
services. (120) Low serum sodium is a poor prognostic indicator in advanced liver 
disease but has multiple aetiologies. Both tools identify very sick patients where the 
risk of dying equates to the risks of transplantation. Concurrent palliative care 
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support should be considered routinely as many patients, even if they are listed as 
eligible, will not be able to receive a transplant due to shortages of donor organs. 
However, these scores are of less value in screening for patients who can benefit 
from an earlier palliative care approach alongside optimal management of their liver 
disease. (121)  
The incidence of chronic kidney disease is rising in an ageing population. Population 
cohort studies show that poor renal function carries a high, all-cause mortality and 
increases deaths from cardiovascular disease significantly. Patients with chronic 
kidney disease and co-morbidities such as diabetes and hypertension are at 1.3 to 3.6 
times more at risk of dying than patients without chronic kidney disease. (122) (123) 
The Charlson Co-morbidity Index (CCI) has been used widely in renal medicine to 
evaluate the impact of co-morbidities on outcomes in people with chronic kidney 
disease. (124) Factors associated with increased mortality rates in patients on 
haemodialysis include; age, dementia, peripheral vascular disease, low albumin, low 
body mass index and diabetes. (125) A detailed modelling study in the USA 
designed to predict six-month mortality for patients receiving haemodialysis so that 
they could be considered for funded hospice care, considered a wide range of 
variables including the Surprise Question and the Charlson Co-morbidity Index. Five 
variables were independently associated with early mortality: older age, dementia, 
peripheral vascular disease, decreased albumin and the Surprise Question when 
combined with the other variables. The other components of the CCI did not add 
value to the model. (126)   
 5a. Clinical Indicators - overview 
There are no valid mortality risk assessment tools for many conditions with a 
chronic, progressive but unpredictable trajectory such as advanced multimorbidity, 
end-stage neurological conditions, frailty or dementia. Prognostic judgements are 
normally based on clusters of clinical indicators. I will look at these four groups of 
advanced conditions in turn and discuss the clinical indicator tools that have been 
developed for use in primary and secondary care over the past decade. 
Multimorbidity is increasingly common and has an important impact on the 
population burden of long term poor health and the risk of premature death. (77) 
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(127) Quantifying this risk is difficult, but poor functional status seems to be a major 
risk factor. (128) Consideration of a person’s total burden of advanced illness is 
important and multimorbidity dominates the health status of older people. Advanced 
multimorbidity, as I will discuss in relation to my next paper, is a clinical scenario 
where there is great potential for better coordination of care and introduction of 
supportive care alongside measures that enable people to live as well as possible with 
poor and deteriorating health. In some patients with cancer, co-morbidities are very 
common and have a significant impact on outcomes. For example, patients with lung 
cancer frequently have underlying chronic obstructive pulmonary disease and heart 
disease. These long term conditions worsen cancer survival and result in a higher 
death rate from non-cancer causes. (129) A systematic review of clinical indicators 
of six month mortality in people with non-cancer illnesses, published in 2011, looked 
at 74 relevant studies and concluded that even though the illnesses differed clinically, 
a universal set of poor prognosis factors was evident. These included: poor 
performance status, advanced age, malnutrition, co-morbid illness, organ 
dysfunction, and hospitalisation for acute decompensation. Patients with 2-4 
indicators generally had a 6-month median survival and this was not altered by 
treatment. (130) An expert group from the Minnesota Evidence-based Practice 
Center undertook a systematic synthesis of published evidence about the prevalence 
of eight overlapping geriatric syndromes and their association with survival and 
institutionalisation, and reviewed models predicting survival in elderly populations. 
A higher burden of illness, perceived poor health, low body mass index, dementia, 
frailty, and disability with poor functional status resulting in marked dependency in 
activities of daily living were all associated with unplanned admissions and increased 
mortality risk. (131) 
People with advanced neurological conditions often have unmet palliative care 
needs. In some conditions, such as motor neurone disease, introducing some aspects 
of palliative care at diagnosis has been recommended and these patients have 
traditionally accessed hospice care in the UK more than those with other long term 
neurological conditions. Challenges in other neurological conditions such as 
advanced multiple sclerosis and Parkinson’s disease include the longer trajectory of 
the illness, difficulty judging prognosis, condition specific treatment and care needs, 
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and care delivery by multiple specialists, primary care teams and social care services. 
‘Red flags’ such as frequent hospital admissions (with pneumonia, recurrent falls or 
urinary tract infections), weight loss, swallowing difficulties and very poor 
functional status may indicate that a patient with an advanced neurological condition 
is deteriorating and could benefit from palliative care for symptom control, family 
support and care planning. (132) 
The syndrome of frailty has been defined as a condition of increased vulnerability to 
stressor events. Frailty is associated with reduced physical and psychological 
reserves that are identified on the basis of clinical signs such as weight loss, frequent 
falls, immobility, muscle weakness/ poor grip strength and slow gait. Patients often 
develop delirium and incontinence. (133) Falls associated with femoral fracture are a 
particularly poor prognostic sign. (134) Frailty occurs predominantly in older people 
and is gaining recognition as a common and important cause of morbidity, unplanned 
hospital admissions and mortality. (135)  
Dementia affects a substantial and steadily growing population of people with great 
potential to benefit from a holistic, palliative care approach and this has been 
recognised by the European Association for Palliative Care in a recent position 
paper. (136) The expert group agreed that timely discussion of the terminal nature of 
dementia as a progressive condition may enhance families’ and patients’ feelings of 
preparedness for the future. Advance care planning, as discussed in section 4, is 
particularly important in an illness where people will lose capacity as they 
deteriorate. As the condition progresses, goals of care gradually shift from life 
prolonging treatments, to maintenance of function and then towards a focus on 
maximisation of comfort. The EAPC group also acknowledged that prognostication 
in dementia is very challenging and that mortality cannot be predicted accurately so 
clinical judgment based on indicators of advancing illness was recommended. A 
prospective cohort study of older people followed up for a year after an unplanned 
hospital admission found that those with moderate to severe dementia had twice the 
risk of dying within a year than other patients, except for those with a low Waterlow 
score. This is a risk assessment for pressure area care needs based on measures of 
appetite, skin condition and mobility, so it is a marker of nutritional status and 
function. (137) Dementia follows a “frailty” pattern of decline, with patients 
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suffering progressively severe disability with a substantial decline in function in the 
last months of life. A variety of scales have been developed and validated for use in 
assessment and care of people with dementia. As the patient deteriorates, functional 
scales for evaluation of performance status and corresponding care needs are mainly 
used. (138) The Functional Assessment Staging (FAST) tool for Alzheimer’s disease 
is widely used to assess people for hospice eligibility in the USA. Stages of severity 
are described as the person gets more dependent on others for help with dressing, 
eating and toileting before developing incontinence, becoming bed bound and losing 
the ability to communicate. (139) However, a systematic review found that the FAST 
tool was not a reliable predictor of 6-month mortality. Other tools include the 
dementia specific, Bristol Activities of Daily Living Scale (BADLS) and the more 
generic Barthel Index, first published in 1965. (140) (141) Being dependent on others 
for help with all activities of daily living suggests the person will have a shorter life 
expectancy. However, there is considerable variation in survival in people with 
dementia and some patients have an unpredictable episodic deterioration with 
infections, fractures or other complications from co-morbidities. This pattern is 
similar to that found in people who have physical frailty. Patients develop 
swallowing difficulties, lose weight and have episodic aspiration pneumonia or other 
infections and are at high risk of pressure sores as they deteriorate. Cognitive 
impairment and communication difficulties make assessment of needs more 
challenging. These problems require good symptom control and careful decision-
making as part of a holistic palliative care approach whatever the person’s predicted 
survival. (142) 
 5b. Clinical Indicators – tools 
In 2001, Lynn published a discussion paper critiquing the 1996 USA National 
Hospice and Palliative Care Organisation eligibility guidelines in people with the 
variable illness trajectories associated with advanced non-cancer illnesses. These 
guidelines consisted of a series of clinical indicators of advanced illness in the four 
major types of organ failure (heart, kidney, lung and liver), dementia, and stroke 
disease. She highlighted the problems associated with seeking to identify people 
accurately as having a prognosis of less than six months. These people would be 
eligible for hospice services funded by Medicare if they were no longer receiving 
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disease modifying treatment. (143) However, these hospice referral guidelines have 
been used as the basis for other tools designed to help clinicians make decisions 
about when to refer patients for palliative care or introduce a generic palliative care 
approach. The most notable is the Gold Standards Framework (GSF) which I shall 
review in more detail because it is widely used in the UK and internationally. The 
GSF combined use of the Surprise Question with clinical indicators derived from the 
American Hospice criteria. This approach started in 1998 as a UK primary care 
initiative aimed at improving palliative care in the community through a structured 
process of patient identification, assessment and care planning. The GSF is now an 
independent organisation delivering a large, international programme of training, 
resources and accreditation from a designated GSF centre in England. There are 
specific versions of the GSF designed for use in different care settings, including 
hospitals and care homes, and to support care of people with dementia. (144) The 
GSF currently uses a ‘Prognostic Indicator Guidance’ (GSF-PIG) tool to help health 
care professionals identify patients for a palliative care approach.  Clinicians are 
advised to decide on the urgency of assessment and care planning based on how 
close to dying they perceive the patient to be guided by a traffic light system of 
green, orange and red coding. This unfortunately highlights dying as the primary 
driver for urgent assessment and focuses users of the GSF-PIG on a need to make 
prognostic judgements before introducing palliative care. (93) The GSF-PIG consists 
of three elements: the version of the Surprise Question that looks for a prognosis of 
days, weeks or months; general indicators of decline and increasing care needs 
suggested by a list of 11 items including deteriorating functional status, increasing 
care needs, co-morbidities, symptoms, lack of treatment reversibility, weight loss, 
hospital admissions, acute events, low serum albumin and patient choice; and finally 
specific clinical indicators of advanced disease for cancer, three of the main types of 
organ failure, advanced neurological conditions which are classified under the 
‘erratic trajectory’ of organ failure instead of being in the third ‘gradual, prolonged 
decline’ group of people with frailty and/or dementia or stroke disease. Evaluations 
of the GSF programme have been largely descriptive or cohort studies in primary and 
secondary care looking at its value in judging when to introduce palliative care. A 
review of the GSF programme (2001-2009) published by the National GSF team in 
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2010 described the seven core outcomes of the Gold Standards Framework and 
looked at evidence of its effectiveness. They found that the GSF improved care 
processes in primary care but the impact on patient outcomes was not clear so a new 
online ‘After Death Analysis’ audit tool was developed to address this. (145) The 
Gold Standards Framework Care Home programme evaluation used this post-death 
audit methodology and found that more patients died in their care home after 
introduction of the GSF programme. As a structured, palliative care intervention in a 
care setting like that with a large number of people in poor health at high risk of 
deteriorating the GSF approach appeared to be effective. (146)  
Other services have also used the GSF-PIG to assess prognosis and identify patients 
for palliative care. A prospective cohort study of patients admitted with acute 
coronary syndrome compared the mortality rate over one year in patients identified 
with the Surprise Question, the GRACE score and one general plus two heart disease 
indicators from the GSF-PIG tool. (147) All three approaches had a negative 
predictive value of over (90%). Using a combination of the GRACE score and GSF-
PIG gave a PPV of 44% and was much better than either tool alone or the SQ alone 
at only 16%. Another study of Scottish patients being managed by nurse specialists 
in the community compared the GSF-PIG with the Seattle Heart Failure model and 
found that neither tool accurately predicted which patients were in their last year of 
life although 86% of the patients did meet the GSF-PIG criteria for the last year of 
life. However, also having chronic kidney disease was a univariate predictor of 12 
month mortality, with a sensitivity of 56% and specificity of 72%. (148) In survey of 
palliative care needs in two English acute hospitals, data were obtained for just over 
500 patients well enough to consent or who had a proxy consenting, a 38% response 
rate. The case notes were reviewed using the GSF-PIG criteria, ward staff were asked 
to identify patients with palliative care needs and patients or a family member 
completed a needs assessment tool. The participants were predominantly older 
people with multimorbidity who had experienced multiple hospital admissions. 36% 
of these relatively ‘well’ patients had two or more general or condition specific GSF-
PIG indicators and there was objective evidence of unmet palliative care needs in the 
patient questionnaires. Staff answering the Surprise Question judged that around 
40% would die within a year. However, they thought that less than 20% had any 
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‘palliative care needs’ and few patients had evidence of a holistic palliative care 
approach to their care other than a DNA CPR form (29%). (81)  
Two recent systematic reviews have identified three other clinical indicator tools in 
addition to the GSF and the SPICT for use in primary care and I will consider these 
next. (85), (89) Maas also surveyed members of the European Association for 
Palliative Care Primary Palliative Care Network. In the Netherlands, the RADboud 
indicators for PAlliative Care (RADPAC) tool was developed via a three-step 
process; a literature search, focus group interviews and a modified Rand Delphi 
study. The purpose of this tool is to improve the care of people with advanced, 
progressive chronic illness in the community by enabling general practitioners to 
identify them and introduce more effective palliative care. Like other tools, it 
contains general and disease-specific assessment criteria, but only for cancer, COPD 
and heart failure. (149) The NECPAL-CCOMS-ICO tool was developed in Catalonia 
(Spain). Drawing on the SPICT and GSF-PIG it uses a public health, population 
screening paradigm for its design and evaluation. The NECPAL tool pays attention 
to psychosocial needs, geriatric syndromes particularly frailty and dementia, and 
signs of progressive functional and nutritional deterioration as well as indicators 
from all the major illness groups. Prevalence screening was carried out by the 
research team who interviewed clinicians in the community, care homes and acute 
hospitals. The clinicians were told to identify people with advanced, chronic 
conditions, choose those they judged to be at risk of dying within 12 months (SQ 
positive) and then look for one or more clinical indicators of palliative care need. By 
using the NECPAL in this way, the group identified 1.3% of the eligible population 
and 7% of those over 65 years. (150) A follow-up, cross-sectional study in the same 
region of Spain identified a prevalence of 1.5% of palliative care needs using 
NECPAL screening. Positive identification was mainly attributable to advanced 
frailty and general clinical indicators of deteriorating health irrespective of individual 
underlying conditions in those patients. The NECPAL tool contains detailed disease 
related indicators and scores taken from other prognostic tools including 
performance status scores. Some of the tests would require hospital-based, specialist 
assessment. The value of adequately mapping population needs for palliative care as 
the basis for improving care is emphasised in this model. However, the Surprise 
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Question is central to the tool and it was developed with the intention of improving 
temporal prognostication (death within a year). More recently the group has 
highlighted the difficulties of making accurate prognostic assessments for individuals 
as opposed to populations. (151)  
 
In 2008, the American College of Physicians published evidence-based guidelines to 
improve palliative care after a detailed literature review spanning 1990-2005. They 
were unable to identify any evidence-based tools that have been validated and shown 
to predict the optimal timing to initiate palliative care services. (152) Indeed, I have 
only been able to identify one generic tool developed specifically for the acute 
hospital setting and designed to support patient identification for both general and 
specialist palliative care. (153) The Center to Advance Palliative Care in Wisconsin 
convened a consensus panel to select criteria by which patients at high risk for unmet 
palliative care needs can be identified in advance for a palliative care screening 
assessment. The consensus panel developed primary and secondary criteria for two 
checklists: one to use for screening patients at the time of admission and one for 
daily ward rounds. The admission indicators were those that are now widely accepted 
including multiple hospital admissions, refractory symptoms, complex care needs, 
deteriorating performance status, weight loss, and the Surprise Question. They chose 
a fairly simple list of illness rather than disease related secondary indicators 
including admission from a care home or hospice programme, long term oxygen use, 
advanced cancer and frailty associated with both cognitive impairment and hip 
fracture. The daily review list focused more on symptom control, complex care needs 
and challenges around goals of care and treatment decision-making. These align well 
with the role and expertise of a hospital specialist palliative care team and are 
effectively referral criteria. The report authors rightly recognise the need for a 
combination of general and specialist palliative care competencies, if the substantial 
proportions of hospital inpatients that need some form of palliative care are to 
receive it. 
 
Developing the Supportive and Palliative Care Indicators Tool  
The challenge of finding suitable tools and approaches for use in routine, busy 
clinical practice in the community, care homes and hospitals with patients who 
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increasingly have not one but multiple advanced, progressive conditions is clear from 
this overview of the tools being used in the UK and internationally. But why develop 
another tool? My goal was to design a simple tool containing well-established, 
evidence-based clinical indicators that would be feasible, acceptable and applicable 
in all care settings. This tool would be able to prompt more effective, consistent and 
timely identification of all patients with deteriorating health due to advanced 
progressive illnesses such that they are at risk of dying. It would support but not 
replace clinical judgements made by health and social care professionals about their 
patients. A simple identification process is combined with suggested actions for 
professionals so that more people can benefit from integrated palliative care 
assessments and conversations about future care planning.  
The six general indicators of declining health found in the SPICT were chosen on the 
basis of their inclusion in many of the tools in the five approaches to patient 
identification that I have reviewed above. These SPICT general indicators have 
remained largely unchanged since the original 2010 version of the SPICT. (154) We 
have only made some minor word amendments as a result of collaborative working 
with our SPICT partners across the UK, in Australia, Canada and some European 
countries. These ensured that the SPICT would be equally effective in other 
healthcare systems and when translated into other languages but did not alter the 
fundamental meaning of the indicators. Table 1 shows how the SPICT general 
indicators map to other published tools for individual conditions discussed above.  
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MM1 = multimorbidity ND2 = neurological disease 
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The six SPICT indicators are found in all four of the most widely used clinical 
indicators tools from primary and secondary care (GSF-PIG, NECPAL, RADPAC, 
and Wisconsin). Some professionals find that these 6 general indicators are sufficient 
to enable them to identify people for proactive assessment. Other professionals and 
specialist teams prefer to combine screening using the general indicators with 
looking for clinical evidence that the patient has one or more advanced, progressive 
illnesses. The advanced conditions section of the SPICT describes clinical indicators 
drawn from disease related mortality tools for organ failure (heart, lung, liver and 
kidney), advanced neurological conditions, dementia and frailty. Indicators found in 
these advanced conditions that are already covered by the generic indicators section 
are not repeated. An important aspect of the international SPICT project has been use 
of the website to build consensus across disciplines and countries about what 
wording should be used so that the indicators are described in ways that convey a 






















The SPICT returns to the principles that were, in my opinion, articulated so well by 
Lynn and Glare when they explored the inevitable uncertainties of illness trajectories 
through the final years and months of life. (87) (143) Use of the SPICT addresses the 
requirement in all care settings for there to be much more systematic identification of 
Designing a clinical tool for patient identification: SPICT 
1. Simple format and clinical indicators that are easily identified. 
2. Contains evidence-based, general clinical indicators of 
deteriorating health and key indicators of advanced conditions 
(including multimorbidity). 
3. Good face validity for health and social care professionals 
working in hospital, community, care home and hospice settings 
in the UK and internationally. 
4. Prompts assessment of unmet supportive and palliative care 
needs as part of routine clinical practice. 
5. Promotes early supportive and palliative care integrated with 
optimal management of any underlying conditions. 
6. Contains accessible language and concepts that can be used to 
start conversations with patients and families about goals of care 
and future care planning. 
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people with advanced conditions, deteriorating health and a risk of dying who often 
experience an illness trajectory that is neither linear nor predictable. SPICT-
identified patients have an individual risk of dying which changes over time, and an 
individual set of care needs. For example, anyone with an advanced condition that 
leads to loss of capacity should be offered early discussions about future care 
planning regardless of temporal prognosis.  Unlike the SQ, as it currently used, the 
SPICT is not intended to offer a binary yes/no answer to questions about whether a 
patient has a short enough prognosis to be identified for a palliative care approach. 
Using SPICT as a screening tool therefore differs from the rather linear ‘traffic 
lights’ approach of the Gold Standards Framework which links urgency of 
assessment to how close to the death the patient is judged to be. (93) The GSF 
guidance maps well to a more predictable, rapidly progressive, cancer illness 
trajectory but it is less helpful for screening the growing population of frail older 
people with multimorbidity. 
 
The urgency of assessment depends on clinician judgement about the patient’s 
current needs and situation. A patient recently discharged from hospital with ongoing 
complex care needs due to rapidly deteriorating performance status or a patient with 
persistent, poorly controlled symptoms would merit more urgent assessment 
regardless of how close to death they may be. The SPICT indicators can therefore 
help to prioritise people with multiple, complex or more pressing problems for urgent 
needs assessment and care planning. Supporting and developing the effective general 
palliative care that is part of the role of most health and social care professionals 
working in the community and in care homes and of many hospital specialists is vital 
so the SPICT lists some of the most important aspects of assessment and care 
planning that they should consider for their patients. Identification with the SPICT is 
only intended to prompt specialist palliative care referral (or referral to other types of 
specialist service) if additional expertise is required. (155)  
 
Having developed the SPICT based on published evidence and ongoing peer review, 
it was of course important for me to test its utility and validity in clinical practice and 
my fourth paper presents the findings of this research. Highet, Crawford (84) I chose 
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a mixed-methods participatory approach that drew on the principles of action 
research as the basis for this study. Action research focuses on generating solutions 
to practical problems. Participating clinicians become co-researchers working in 
partnership with the research team. Together they are actively involved in a cyclical 
process of data collection, analysis and interpretation. (156) (157) We ran the study 
in a large tertiary hospital and worked with the multidisciplinary team in four 
specialist units in turn. Each unit cared for people with one of the four major types of 
organ failure. Emerging findings were fed back to the clinical team for their 
comments after each of the eight week study periods and to all the units as they 
joined in the study. This provided us with an in-depth understanding of the way the 
SPICT indicators were being used and interpreted by hospital specialists who had 
expertise in using some of the other methods of identification reviewed above.  
Table 2: Summary of SPICT evaluation study methodology 
Literature 
review 
Peer review Case study series 
Regular review of 






literature review of 
papers on patient 
identification for 
palliative care. 
Open access website with 
SPICT™ study information 
and the current version of 
the tool. 
 
Open invitation to 
interested clinicians and 
policy makers in the UK 
and internationally to 
comment on SPICT™ 
content and join the 
project.  
 
Promotion of the SPICT™ 
programme at UK and 
international conferences 
and through peer to peer 
contacts made by SPICT™ 
collaborators. 
  
Mailing list of collaborators 
receiving regular updates 
about the SPICT™ who  
wished to use it in their 
own practice and 
contribute to ongoing 
development through 
multiple cycles of review 
and redesign. 
Screening all unplanned 
hospital admissions of 
patients with advanced 
conditions in four specialist 
units (renal, liver, cardiac, 
respiratory) using SPICT™ 
criteria; comparison with 
standard tools: SPARRA 
(Scottish readmission risk 
score), Charlson Index 
(renal), UKELD score 
(liver).  
 
Six month follow-up of 130 
identified patients from the 
four units for clinical and 
service use outcomes. 
Retrospective analysis of 
service use in last six 
months for 62 patients who 
died within 12 months. 
 
An in-depth, qualitative 
study of the admission and 
discharge processes of 
SPICT™ identified patients 
in the four units including 
interviews with patients, 
carers and GPs, staff 








Using the SPICT enabled ward medical and nursing staff to identify patients. Non-
medical members of the team felt more empowered to ask the medical staff questions 
about future care planning for the people they were identifying. Previously ignored 
inconsistencies in the approach to medical decisions about cardiopulmonary 
resuscitation were raised by nurses and led to more open discussions in the renal and 
liver teams about what constituted ‘ward level’ care. The 130 SPICT identified 
patients from the four units were followed up for 12 months. After 6 months 45/130 
(35%) had died and by 12 months there were a further 17 deaths (62/130, 48%). We 
attempted to screen all unplanned admissions to each unit but this was only possible 
in the renal and liver units and we were unable to obtain data on all deaths for each 
unit at 12 months. Our primary objective at the outset was to test the utility and 
feasibility of the SPICT in clinical practice and not to evaluate its prognostic 
predictive value. This could be done in future studies, bearing in mind the limitations 
of this approach to patient identification that I have already discussed. Patients who 
died within the first six months had a higher number of clinical indicators overall but 
the pattern of these varied by illness group. Almost all the patients with advanced 
respiratory disease had a poor performance status (96%) and many also had poorly 
controlled symptoms (75%). Patients with liver disease were the most likely to have 
had two or more unplanned admissions in the previous six months (74% of that 
group). A third of the renal group had significant weight loss but this was uncommon 
in patients with cardiac or respiratory disease. These findings support clinician 
judgement, informed by a series of key indicators, as an effective approach to 
screening patients with long term conditions for deteriorating health and unmet 
holistic needs.  
 
The SPICT is primarily a descriptive tool designed with, and for use by, practising 
clinicians to assist clinical judgements. Face and content validity are of primary 
importance. By building up a diverse, online peer review group, I was able to address 
validity further through drawing on expert opinion in the selection of indicators and 
the wording chosen to describe them. A Delphi survey uses a series of rounds of 
questions sent to a panel of experts to try to build consensus.(158) This approach has 
been used to derive a basic dataset for describing a palliative care cancer population. 
42 
 
In that study, a large panel of international experts took part in five structured rounds 
questionnaires to reach 70% consensus on a set of variables. (159) However, I 
decided that Delphi methodology would be too prescriptive and restrictive for a 
flexible, iterative process of dialogue and debate about clinical constructs and the 
language and meaning of the terminology used to describe them in the UK and 
internationally. The SPICT online group members numbered over 30 clinicians from 
different disciplines who were working in specialist palliative care, hospital 
specialties and in primary care. They provided ongoing peer review of each version 
of the SPICT that was developed during the evaluation study and their comments 
were integrated with those of the participating clinical teams. By the end of the 
project, no further changes were proposed to the indicators. Peer review and 
discussion about the SPICT indicators has continued via the website and is reflected 
in subsequent minor amendments to the ways in which the indicators are described. 
This was necessary because the SPICT is now being used widely outside the UK 
National Health Service. (Appendix C: SPICT 2015) 
 
Criterion validity compares new tools with established measures. In my SPICT study 
group, I chose a key indicator of deteriorating health (unplanned hospital admissions) 
in the cohort of patients identified by the clinicians using the SPICT. In a comparison 
with the population based Scottish Patients at Risk of Readmission and Admission 
(SPARRA) score provided by Information Services Division (ISD) I found relatively 
high mean SPARRA scores of 65% in the SPICT identified group who died and 60% 
in those still alive at 12 months. (160) Comparisons with the Charlson renal co-
morbidity index for patients with kidney disease and the UKELD score for the liver 
unit patients confirmed that SPICT identified patients had a high mortality risk as 
assessed with these tools. (120) (124) The Surprise Question is a widely used 
measure, so we asked participating clinicians to answer the SQ for each patient who 
had SPICT clinical indicators present. Use of the SQ identified 79% of the 62 SPICT 
identified patients who had died by 12 months but 71% of the SPICT identified 
group of 130 patients as a whole; a sensitivity of 79% but a low specificity of 29%, 
in keeping with the studies I have discussed earlier. Reliability (the degree to which 
an assessment tool produces stable and consistent results in multiple tests and by 
different users) is harder to evaluate in relation to tools such as the SPICT which are 
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based on qualitative descriptors combined with professional judgements. We asked 
our participating teams to use the SPICT indicators to help them make assessments 
as they would do in routine clinical practice to test the utility of the SPICT. Future 
studies could be designed to compare assessments made by multiple clinicians. The 
SPICT identified patient group demonstrated the same non-linear illness trajectory as 
that found in a large, Scottish inpatient cohort study. Clark, Armstrong (69) 
However, the SPICT identified patients had a higher risk of dying than the cross-
sectional cohort of hospital inpatients evaluated retrospectively by Clark et al. (35% 
v 21% at 6 months and 48% v 29% by 12 months). As in the population survey, more 
of the patients we identified died within the first 6 months of follow-up than in the 
subsequent 6 months. 
 
My own specialist palliative care team works in the participating units so I needed to 
be mindful of potential bias and conflicts of interest in data generation and 
interpretation. A social scientist was employed to undertake qualitative interviews 
and observations in each ward area. A purposive sample of 20 SPICT™ positive 
patients with diverse demography and clinical history was identified by ward staff 
and recruited for interview at home soon after discharge, four of whom died and two 
withdrew. Nine carers participated in a joint interview and ten of the patients’ 
general practitioners were interviewed by telephone. The researcher attended daily 
and weekly meetings and ward rounds, supplemented by periods of direct 
observation in each unit using a modified version of The Workplace Culture Critical 
Analysis Tool (WCCAT). (161) The WCCAT observation approach in clinical 
settings is a form of ethnography: a research process where a trained observer enters 
an area and seeks to gain multiple perspectives of what is happening in that setting 
through detailed observations, and derive explanatory descriptions of the underlying 
culture. The WCCAT is used to enable staff to gain a greater understanding of 
workplace culture that can then inform practice development and a participatory 
change process. It was well suited to this project where we wanted to introduce a 
new tool for patient identification but also facilitate wider changes in attitudes and 
clinical practice among the staff. The patient/ carer and GP interviews were digitally 
recorded, transcribed and entered into the qualitative data analysis package NVivo 
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along with data from individual staff perspectives and ward/ team meeting 
observations. The researcher and I read the transcripts and we worked together to 
develop a thematic analysis framework identifying key issues relating to the patient 
journey through admission, inpatient care, discharge and follow-up in the community 
using a priori research questions derived from key palliative care policy documents 
as well as emergent issues raised by interviewees. Contrasting themes and issues 
were examined with a view to developing explanations of participants’ experiences 
and understandings, initially from different perspectives and then synthesised across 
all participants. These data were not included in the paper that forms part of this 
thesis but provided valuable insights into the wider aspects of effective, early 
palliative care of which identification is only a part. As in my study of anticipatory 
care planning with general practitioners (Paper 3), and my next paper reporting the 
experiences of people with advanced multimorbidity following hospital discharge 
(Paper 5), attitudes to living with advanced illness and the negative connotations 
associated with ‘palliative care’ were of prime importance in influencing the 
behaviour of professionals, patients and family carers. 
 
Before discharge, nursing staff prepared patients and families for the likelihood of 
further admissions and gave advice about warning signs of deterioration and 
strategies for dealing with these events. Care planning stopped short of a broader 
discussion about goals of care or proactive anticipatory care offering holistic support 
at an earlier stage alongside medical treatment and social support at home. Patients 
and carers varied in their coping strategies. Some minimised the symptoms 
associated with their condition and others tried to protect close family members: 
I wasn’t even aware that I had it.  I think they mentioned up in the (hospital) months 
and months ago, that there was a slight something.  But they sorted it with 
medication…. I don’t think there’s anything up with my kidneys at the moment.  Is 
there? (Renal: Patient 2) 
 
I don’t really talk to [husband] very much about it, because I don’t want him to get 
any more worried, because he gets very depressed.  So we don’t talk about it all 
that much.  But, I talk to my sister a lot. And my home help, she’s a gem. 
 (Renal: Patient 1) 
 
Many people seemed to cope with the emotional strain of living with a chronic life 
limiting condition through a process of ‘positive denial’. People who adopt this 
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strategy have an accurate perception of their prognosis but dissociate that awareness 
from its personal impact, preferring instead to ‘hope for the best’ and ‘take each day 
as it comes’. Others would have liked more open conversations:  
‘I think in the long term my kidneys are not as good as they should be and they 
won’t improve. They’ll possibly deteriorate a bit.  But I’m not worried about that, 
I’ll cross that bridge when we come to it. I think if I thought about it you would go 
round the bend.’ (Renal: Patient 5) 
 
‘I’m past thinking about it. Just got to get on with it, just, kind of a positive 
attitude...’ (Respiratory: Patient 1) 
 
‘At first it was very strange, very daunting. I was scared, like, to go out. Even if 
someone was just coming to talk your feelings through, you know, like, when I 
asked if I was going to die, no-one ever mentioned it again, it was, sort of, put to the 
side.’  (Liver: Patient 1) 
 
Professionals described the difficulties of attempting to address future planning 
with patients whose coping mechanisms seemed to them to leave little room for 
open discussion. Senior nurses tried to use triggers such as an unplanned hospital 
admission to ‘plant a seed’. Other, less experienced staff said they lacked the 
necessary skills and confidence to initiate such discussions with patients and some 
felt that it was beyond their remit.  Overall, there appeared to be a strong belief that 
few patients with these advanced, non-malignant conditions wanted to engage with 
a specific discussion about end of life issues in advance. Yet, some of clinicians 
clearly struggled with concerns about the burdensome nature of life-prolonging 
treatment in people who were clearly deteriorating. 
‘You wouldn’t do it to your dog’ (Renal: Consultant 1) 
 
It seemed that little had changed since my earlier studies (Papers 1-3). Palliative 
care remained strongly associated with treatment withdrawal and dying amongst 
patients and professionals in primary and secondary care. Negative perceptions 
about openly discussing death and dying are a significant barrier to effective 
communication and care planning. (162) Few of the patients we interviewed were 
on a primary care palliative care register, although one general practitioner did 
highlight the importance of changing the focus of care, and another looked to 
hospital discharge information for guidance as in my third study: 
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‘I don’t know. I think it’s unlikely she’d be on the register because she doesn’t have 
a diagnosis like cancer, and certainly not at this stage.’ (Liver: GP 2) 
  
‘She wasn’t in the terminal phases of dying. She is very much alive and has things 
to live for.’ (Respiratory: GP 2) 
 
‘I think there’s a lot more could be done for these patients with advanced non-
malignant disease. With cancer patients it’s a bit more of a well established 
pathway.  You want to know if there’s been any “major hiccups” during the 
admission, what the patient’s been told, and if there’s anything they expect us to do 
for follow-up.’ (Renal: GP 7) 
 
This was a successful, mixed-methods study evaluating a simple, clinical tool 
(SPICT) based on readily identifiable indicators to support identification of patients 
with advanced conditions and unmet care needs who were at risk of deteriorating. 
Multi-professional teams were able to identify patients as part of their routine clinical 
practice and we found that those patients had multiple unmet supportive and 
palliative care needs and a high risk of both re-admission and dying. By the end of 
the study, we had modified the SPICT by improving the clarity of the language used 
for the descriptors. We decided not to include the Surprise Question because of its 
focus on temporal prognostication and its low specificity and we removed blood test 
results that were difficult to obtain and interpret in all care settings. The SPICT is 
available to download from a designated, open access website (www.spict.org.uk) 
and is grounded in the realities of clinical practice. This has led to the SPICT being 
adopted widely in the UK and internationally. It has been endorsed by many 
individual clinicians, professional organisations, health policy makers in Scotland, 
England, Ireland, several member states of the European Association for Palliative 
Care (facilitated by translations into French, German, Spanish and Dutch) and in 
Australasia. Future studies may include mapping SPICT indicators in prospective 
population studies of people from different care settings, inter-rater reliability testing, 




6. Multimorbidity is now the norm, but ‘planning for dying’ is not. 
(Paper 5) 
‘It is much more important to know what sort of patient has a disease than what sort 
of diseases a patient has.’         
        Sir William Osler 
After completing my evaluation of the SPICT in an acute hospital setting, we went 
on to conduct a multi-site, ethnographic and serial interview study of care 
coordination provided for people with advanced conditions recruited in an acute 
medical admissions unit in Scotland, a large primary care team in the north of 
England and a respiratory medicine team in London. The study was funded by the 
National Institute for Health Services Research (08/1813/258). Three social science 
researchers worked collaboratively and conducted ethnographic observations in the 
study sites, qualitative interviews with a purposive sample of patients, their carers 
and case linked professionals, and consultations with service providers. Patients were 
identified by the clinical staff using SPICT clinical indicators to guide an assessment 
of whether they thought the patient was deteriorating and at risk of dying within 
about a year. We found little evidence of any systematic approach to introducing 
supportive and palliative care except for the patients with lung cancer attending the 
respiratory medicine clinic. Fragmented care coordination due to poor identification 
of patients with multiple health problems and at risk of deteriorating and dying was 
the norm. The mean age of the 56 people recruited was 71 years (range 41-92) and 
by nine months 29% had died. (163) Many of those identified by the health 
professionals were frail, older people with multimorbidity. Working with the study 
lead researcher, I therefore undertook a secondary analysis of the data generated 
from 87 serial interviews with 37 patients with advanced multi-morbidity and 17 
family carers. This subgroup had a mean age of 76 years and 30% died during the 
study period. The main aim was to explore these people’s understanding of their 
health problems and their experiences of health and social care. (164) Patients with 
cancer often had a key professional or coordinated care from their general practice. 
In contrast, people with multiple advanced illnesses and their carers described the 
ongoing challenges of having to navigate multiple care systems, services and 
professionals. Polypharmacy and frequent medication changes compounded their 
problems and were already well described. (165) The most striking findings from this 
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study were the impact of the understanding people had of their health problems and 
the coping strategies many adopted to make sense of their experiences of illness, 
treatment and care. The dominant understanding of progressively, deteriorating 
health was one of being ‘old rather than ill’. This meant that people focused on living 
as well as they could in the present, tried to maintain autonomy and independence by 
not asking for or accepting services, and did not consider planning ahead. Even in the 
context of declining health and increasingly frequent episodes of acute deterioration, 
people often chose not to think about the patient’s risk of dying and they associated 
palliative care with imminent death which meant it had no relevance to their 
perceived needs or circumstances. General practitioners described a reactive 
approach to the care of patients who chose not to ‘bother the practice unless they had 
a problem’ and were not identifying people with an uncertain prognosis for their 
palliative care register even though they were not surprised to learn of the patient’s 
death. 
‘I personally don’t want anybody to come in because we cope ourselves and the way 
we cope is because we cooperate with one another you know.’ (Carer of P2—female, 
76: heart failure, renal failure, diabetes) 
 
‘I think I’d rather be positive. I think I’m not going to get worse.’  
(P5, female, 66: liver failure, diabetes, heart disease) 
 
‘I can’t say I was altogether surprised. He did have a pretty extensive vascular 
history. He’s probably one of those patients who quite commonly slip through the net 
when it comes to palliative care needs.’  
(GP of P32 – male, 75: mitral valve disease, heart failure, peripheral vascular 
disease) 
 
Delivering better care for the increasing numbers of people living and dying with 
multiple advanced conditions poses major challenges for health and social care 
systems across the economically developed world. (127) Specialist services and 
clinical guidelines still focus on optimal management of single diseases and often 
neglect wider social determinants of health. (165) (166) Primary care services have 
been busy addressing targets for health promotion and self-management that seek to 
maintain the well-being of people living with long term conditions and avoid 
hospitalisation. There is a pressing need to face the challenges of providing 
coordinated, generalist care for people with multimorbidity. (90) (167) (168) This 
includes being able to recognise when people might benefit from a holistic 
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supportive and palliative care approach to care, planning for the management of 
episodes of acute deterioration, and continuity of care for people whose health is 
declining. (77) Jerant has contended that only treatment intent distinguishes palliative 
care from other forms of medical care. (169) Most current medical care seeks to 
prevent death. By contrast, in palliative care, illness is treated to maintain or slow the 
rate of decline in quality of life. This type of holistic, general care is widely 
applicable and acknowledges the prolonged process of nearing death faced by many 
older patients who have chronic illnesses. It takes account of the wide variation in the 
point in time at which patients, families, and professionals perceive that death is 
approaching. He proposes a ‘TLC’ model of care for older people: 
 Timely and Team orientated – proactive care delivered by a broad 
multidisciplinary team and diverse services. 
 Longitudinal – palliative measures integrated with appropriate illness-focused 
treatments that evolve over time. 
 Collaborative and comprehensive – care delivery and planning involving the 
patient, those close to them, and any professionals, services or community 
support able to help with holistic care needs. 
Like the hospital patients we identified in the  SPICT screening study described 
above, most people with multimorbidity interviewed for this study had a strong 
desire to maintain ‘normality’ for as long as possible. Talking about death or 
planning for dying was not part of that perspective. Even among patients with cancer 
attending a Scottish oncology service, many wanted honesty from their health care 
professionals but also preferred a degree of ‘prognostic ambiguity’ which allowed 
them to retain hope and live well in the present. (170) Older people in poor health 
tend to be particularly concerned about loss of autonomy and independence. (171) 
While death was an acknowledged reality for frail older people, it was not at the 
forefront of their concerns. People living with long term organ failure conditions 
worried more about having another acute exacerbation than a potentially fatal 
outcome. (172) The challenge here is how to implement effective approaches to care 
continuity and coordination that will support people who have advanced illnesses and 
deteriorating health to live well with inherent uncertainty while engaging with 
planning for what are inevitable episodes of deterioration that may or may not end in 
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the person’s death. (173) An important first step is for everyone to accept and 
acknowledge openly the undeniable fact that when and how people deteriorate and 
die will always be unpredictable. Even when people are very close to death some 
uncertainty remains. (174) Secondly, talking about ways of managing uncertainty 
needs to become a core element of future care planning. Smith has proposed a 
framework aligned with patient priorities and consisting of three central tasks that 
clinicians can use to help patients and families manage uncertainty as part of future 
care planning. The first task is to explore people’s expectations, be honest about the 
boundaries of our knowledge of what will happen, and normalise uncertainty about 
prognosis. The next is to talk about the emotional difficulties of living with 
uncertainty, before finally moving on to discuss what patients and families would 
find helpful as they manage the effect of uncertainty on their ability to live in the 
here and now. (91) An important trial of early palliative care in lung cancer showed 
that it was possible to plan for future episodes of deterioration with patients and 
families and talk about their values and priorities sensitively without disrupting what 
appeared to be a common view among patients and professionals that “thinking 
about dying” may not be helpful for people who are living with the demands of 
advanced illnesses by “living each day as it comes”. (175) (176) 
 
Managing uncertainty has long been a core aspect of general practice so primary care 
services should play a central role given that people in the UK spend about 90% of 
their last year of life at home or in another community care setting.(72) (177) A 
literature review of patient-professional communication about advance care planning 
for people with advanced cancer looked for best practice recommendations that could 
help those with other life-limiting conditions and suggested that the optimal context 
for future care and end-of-life discussions was within a trusting, long-term 
relationship that offered open and repeated negotiations around patients’ preferences 
for information. (178) However, advance care planning alone is not the answer 
because it asks people to make projected decisions about future situations when their 
mental and/or physical health will be much poorer. An American interview study 
with older people elicited barriers to thinking about planning, discussion with family 
and friends, discussion with professionals, and documentation of an advance 
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directive. The most prevalent barrier at all stages was a perception that planning 
ahead in this way was irrelevant because these people perceived themselves as still 
‘‘too healthy’’, even though close to 70% reported having fair to poor health. (179)  
 
Anticipatory care planning offers a more flexible alternative approach that is more 
grounded in people’s current reality. Anticipatory care plans are of particular value in 
guiding the management of episodes of acute deterioration and should be tailored to 
individual clinical and personal circumstances and regularly updated. A structured, 
anticipatory care planning intervention in the north of Scotland, based in primary 
care, was widely acceptable to patients, families and professionals and effective in 
reducing hospital admissions among frail older people. (180) Introduction of an 
electronic, Key Information Summary (KIS) for general practitioners throughout 
Scotland to record anticipatory care plans for any patient at risk of deteriorating has 
led to a marked increase in the number of people with advanced conditions that have 
such care plans. No direct association between the KIS and ‘palliative care’ has made 
it widely applicable and much more acceptable to professionals and patients than its 
predecessor, the electronic palliative care summary. (181) The KIS provides the 
necessary infrastructure for recording and sharing information between primary and 
secondary care and with out-of-hours services. A well-established, electronic record 
system in London is making a significant contribution to improvements in care 
coordination for people with declining health. It can be updated and viewed by a 
range of professionals and services and has a clear and accessible name – Coordinate 
My Care. (182) 
 
Experiences and expertise gained from over ten years of research, the growing 
evidence base supporting integrated supportive and palliative care, and the benefits 
of the Scottish Key Information Summary were the basis for designing a pilot trial of 
a future care planning intervention for people with advanced heart disease being 





7. Anticipatory care planning with people with advanced heart disease: 
a pilot randomised controlled trial. (Paper 6) 
 
 ‘Talk, Plan, Live‘    Dying Matters Collaborative 
After ten years, I turned my attention back to the patient group that first prompted 
my research into how care could be improved and services developed to respond 
more effectively to people’s individual illness journeys and needs. I began with two 
studies involving people who had advanced heart failure. Even then, we recognised 
that many people were excluded from the structured support and care coordination 
offered to patients with left ventricular dysfunction by virtue of having other types of 
heart failure, ischaemic heart disease or multimorbidity. Future care planning 
provides a framework for discussing a range of problems with many more patients 
living with advanced heart disease and their families. This approach can be 
introduced much earlier needs to start well in advance of ‘end-of-life’ care. (24) I 
developed an integrated model of future care planning for people with advanced 
heart disease that brings together advance care planning and anticipatory care 
planning and updates the Framework published in my 2009 paper. (34) 
Working with a cardiologist who has a special interest in advanced heart disease and 
palliative care, together we went on to design a pilot, stepped-randomised future care 
planning trial. (183) The trial intervention included and addressed what we know to 
be key components of an effective, integrated palliative care approach: 
 Use clinical indicators to identify people with deteriorating health. 
 Offer accessible patient information about future care planning.  
 Integrate optimal illness-focused management with other palliative measures 
directed at quality of life. 
 Use effective communication approaches to open conversations about the 
future, what matters to patients and families and managing uncertainty.  
 Agree individualised anticipatory care plans for managing acute episodes of 
deteriorating health. 
 Discuss continuity of care and the benefits of an anticipatory care plan 
recording key shared decisions within a Key Information Summary. 
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 Offer information about advance care planning relating to nominating a 
power of attorney and making decisions about CPR and implantable devices. 
 Support people to engage with future care planning discussions within a 
longitudinal relationship with a specialist heart nurse able to offer open and 
flexible responses to patient and family preferences for information. 
 Liaise with the patient’s general practitioner and support the primary care 
team’s central role in coordinating care of people with advanced 
multimorbidity. 
 
Randomised controlled trials in palliative care are notoriously challenging to 
design and implement. (184) We followed the Medical Research Council 
guidance for trials of complex interventions and designed a mixed-methods, 
Phase I and Phase II pilot randomised trial. (185) In addition, we drew on 
methodology used to develop complex care interventions for people with 
dementia and the holistic management of breathlessness. (186) (187) Mixed-
methods approaches to trial design enable better understanding of whether and 
how an intervention works (or does not work) and inform the design of 
subsequent studies. (45) The Phase I study reported in my sixth paper enabled us 
to refine the study design and explore important aspects of feasibility and 
acceptability with patients, carer and key professionals. (183) A social scientist 
facilitated focus group discussions with 15 patients and carers from two local 
support groups and interviewed a diverse sample of eleven health professionals. 
The interviews and focus groups were guided by a flowchart of the proposed 
intervention and a patient-held ‘Thinking ahead’ guide based on the one I had 
written and published with my third paper. (49) The Phase II trial consisted of a 
stepped intervention where eligible patients were randomised to either early 
intervention (before or soon after discharge from hospital) or delayed 
intervention (12 weeks later). Recruited patients received a copy of my refined 
‘Thinking ahead’ guide as part of the study information and a meeting was 
arranged for them and their main carer with the trial cardiologist and specialist 
heart nurse to talk about their heart problems and future care planning. I provided 
advanced communication training in talking about deteriorating health, shared 
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decision-making and managing uncertainty for the cardiologist and specialist 
nurse using evidence based approaches to communication about serious illness 
and patient-centred future care planning. (176) (188) (189) (190) (191) Central to 
these discussions is a 6-step approach and use of communication skills such as 
hypothetical questions, generalisation and linking hopes with concerns. 
 
During the 12 week follow-up period, the patients and families could contact the 
specialist nurse by telephone and she visited them at 6 and 12 weeks to review 
their care plan and update the primary care team and hospital services.  Quality of 
life, measured with a standardised questionnaire (EQ5D), was the primary 
outcome. (192) Patients and carers also completed questionnaires recording 
anxiety and distress (Kessler score). (193) Service use data including 
hospitalisations was recorded. Supplementary data about people’s experiences 
came from qualitative interviews with a purposive sample of patients, carers and 
their general practitioners.  
 
It was important to design an intervention that would be feasible and effective as 
part of routine clinical care. An unplanned hospital admission is a key clinical 
indicator for identification of people with declining health due to advanced heart 
disease so we chose this entry criterion. In order to complete the trial within a 
finite time frame and demonstrate that those recruited had advanced heart 
disease, we also set an additional eligibility criterion of a 12-month mortality risk 
of 20% or greater at the time of discharge using the GRACE score for patients 
with an acute coronary event or the EFFECT score for people with heart failure. 
(112) (115) An initial assessment by a cardiologist reassured patients, families 
and other professionals that treatment of their heart condition would be 
optimised. Knowing that busy general practitioners find guidance from hospital 
specialists helpful in identifying people for a palliative care approach and 
appreciate timely information with clearly defined actions, we decided to send 
the initial and reviewed future care plans to the practice by secure email in a 
format ready to be uploaded into the patient’s Key Information Summary. (181) 
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Ongoing support for patients and families and a point of contact for professionals 
from the nurse specialist provided the necessary continuity of care over time. 
 
The trial was completed in March 2015 having successfully recruited and 
randomised 50 patients with advanced heart disease and has been presented at the 
European Association for Palliative Care Conference and submitted for peer 
reviewed publication. The intervention increased power of attorney nomination, 
CPR decisions and anticipatory care plans. There was no increase in anxiety or 
distress (Kessler score - E 16.7 (7.0) v D 16.8 (7.3), p=0.94). Quality of life 
remained stable twelve weeks after discharge (EQ5D – E 0.54 (0.29) v D 0.56 
(0.24), p=0.86). This is important given concerns that early palliative care might 
cause psychological harm by disrupting people’s coping mechanisms. The 
intervention was in fact valued greatly by patients, carers and general 
practitioners although the numbers were too small and the period of follow-up 
too short to demonstrate any significant impact on hospitalisations or other 




8. Conclusions: a 2020 vision for integrated palliative care.  
 
Health policy in Scotland and other parts of the UK aims to deliver person-
centred care that respects the values and priorities of individuals, their families 
and communities. Promoting health and wellbeing are given prominence, but so 
too is the need for integrated care of an ageing population living with 
multimorbidity. (194) Alongside these aspirations, comes a growing recognition 
that death and dying are an inevitable part of life and good care of people with 
deteriorating health due to one or more advanced illnesses in all care settings is a 
core responsibility of all health and social care services working in partnership 
with local organisations. Making this a reality requires high quality research 
which can inform changes in the way services are configured in the future to 
ensure that we are able to deliver what we know matters to patients, families and 
professionals. This critical review has therefore highlighted the two major 
challenges facing palliative care in the 21st Century, namely how to introduce a 
holistic, quality of life focused approach earlier in the illness trajectory of all 
advanced conditions and how to integrate that approach with effective, well-
coordinated, continuing care of people whose health will decline to death in 
uncertain and unpredictable ways. 
 
My research over the past 10 years has focused on people with heart disease as a 
proxy for other types of organ failure and more importantly for multimorbidity. It 
was evident in my two initial research studies involving people with advanced 
heart failure (Paper 1 and Paper 2), in the advance care planning study with 
general practitioners (Paper 3), when we identified people with deteriorating 
health after an unplanned hospital admission using the SPICT tool (Paper 4) and 
in my study of the experiences of people living with multimorbidity (Paper 5)  
that patients, families and professionals continue to find talking openly about 
death and dying difficult despite widespread public awareness campaigns. (195) 
If earlier and more systematic patient identification (Paper 4) is to be of real 
value, we need to improve ‘prognostic awareness’ and promote future care 
planning as a widely accepted process of well-coordinated planning shared 
between primary and secondary care that is responsive to people’s priorities and 
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supports genuine shared decision-making over time. Our pilot trial of future care 
planning with people who have deteriorating health due to advanced heart disease 
(Paper 6) has shown that this is challenging but achievable.  
 
It could be argued my six research studies were all conducted in one part of 
Scotland so might have limited generalisability. However, this work when seen in 
the context of the wider literature and the evidence base for effective supportive 
and palliative care is widely relevant. The research findings in my papers 
resonate with the work of many other researchers cited in this review. In 
particular, we have understood and clearly articulated the importance of helping 
people to live well with the uncertainties of declining health whilst also being 
supported to plan ahead for what might happen when an episode of deterioration 
happens. This is the way forward for future care planning and should replace the 
narrower concept of advance care planning in which people are expected to make 
concrete plans for dying too far in advance for those plans to be reliably 
meaningful, applicable or helpful. Professionals still have to balance their 
responsibilities to share information about deteriorating health and offer patients 
and families the benefits of anticipatory planning and care coordination while 
taking care not to damage people’s abilities to maintain a sense of normality and 
retain their autonomy. Offering clear guidance on ways to communicate, share 
information sensitively and engage people in an ongoing process of future care 
planning helps professionals have good conversations with patients and families. 
Together they can then reach better shared decisions about the things that should 
be planned in advance, such as nominating a Power of Attorney in case a person 
loses capacity for decisions, and accept those things that might well remain 
uncertain until much later on, such as place of death or treatment and care 
options. Once professionals feel confident and competent in having these 
conversations, they can use resources like the Key Information Summary to 
document individualised, anticipatory care plans. If people at risk of deteriorating 
have an up to date Key Information Summary that means any professional or 
service caring for them will be able to access information about what care and 
treatment options have been discussed already and any plans or priorities that 
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have been agreed in the event of a sudden change in the person’s health or 
circumstances.  
 
To do this successfully of course requires timely, proactive identification of those 
at risk of further deterioration in their health and of dying. My major contribution 
to palliative care research and clinical practice in the UK and internationally over 
the past 10 years has been the development and validation of an instrument to do 
this, the supportive and palliative care indicators tool (SPICT). For that reason, I 
have devoted a substantial section of this review to discussing the rationale for a 
different approach to patient identification. I have explained why a new tool was 
needed and shown how I used a detailed understanding of the strengths and 
limitations of the five main methods of identifying people for palliative care 
assessment to develop the SPICT in collaboration with an international 
community of colleagues. I have shown why targeting our efforts towards trying 
to predict when an individual patient will die is not only futile but potentially 
harmful because it often delays a review of care priorities and makes patients, 
families and professionals focus on preparing for death instead of planning for 
future episodes of deterioration. In the SPICT, I advocate use of probabilistic 
predictions of risk that someone may deteriorate and die. I have combined this 
with readily identifiable signs that a person’s health is declining such that 
interventions to address care needs, symptom control, information and future 
planning should be initiated. The guide on the designated SPICT website 
encourages professionals to use the tool to help them to judge when to make an 
assessment of unmet needs that may include sharing information about the 
person’s health problems and talking about what might happen. Clinicians should 
consider symptom management using palliative care measures integrated with 
appropriate treatment of underlying illnesses, psychological and family carer 
support, practical help with daily tasks, companionship and spiritual care. For 
some people, labelling this person-centred, holistic care as ‘palliative care’ might 
be helpful but for many others it will be indistinguishable from good quality, 
continuing care delivered by multiple professionals and services. The success of 
the SPICT programme, which now has many partners around the world, is 
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testament to the acceptability and utility of the SPICT as a tool designed to 
support better palliative care in all care settings. 
 
Successful completion of a pilot, randomised controlled trial of an integrated 
future care planning intervention has demonstrated the potential benefits of the 
approach to palliative care discussed in this review. This study demonstrated that 
it was possible to combine patient identification with optimal care of underlying 
health problems, holistic care and symptom control all supported by sensitive and 
effective conversations about future care planning based on people’s 
understanding and expectations. Identifying people in secondary care and then 
promoting and enhancing care coordination in the community proved an effective 
model that merits further evaluation.  Future research needs to build on this work 
in larger trials with other patient groups in multiple centres. A parallel 
programme of engagement with service users would ensure that the perspectives 
of patients, families and the wider community continue to inform our thinking in 
palliative care research and development. There are many people with advanced 
progressive, life-limiting conditions, frailty and multimorbidity who stand to 
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